Drug treatment of chronic obstructive pulmonary disease on two levels of patient care: degree of compliance with recommended protocols (Q44442777)

3 December 2017

Drug treatment of chronic obstructive pulmonary disease on two levels of patient care: degree of compliance with recommended protocols (English)

1 reference

reason for deprecated rank

3 December 2017

Tratamiento farmacológico de la EPOC en dos niveles asistenciales. Grado de adecuación a las normativas recomendadas (Spanish)

marking inconsistent with the registered/official identifier/name

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(03)75361-7

chronic obstructive pulmonary disease

2 January 2024

main subject

1 reference

inferred from title

author

Javier de Miguel-Díez

1

object named as

J. de Miguel Díez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12749801

2 January 2024

author name string

J. L. Izquierdo Alonso

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12749801

2 January 2024

J. M. Rodríguez González-Moro

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12749801

2 January 2024

P. de Lucas Ramos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12749801

2 January 2024

J. Molina París

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12749801

2 January 2024

language of work or name

Spanish

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12749801

2 January 2024

publication date

1 May 2003

1 reference

full work available at URL

3 December 2017

https://api.elsevier.com/content/article/PII:S0300289603753617?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(03)75361-7

https://api.elsevier.com/content/article/PII:S0300289603753617?httpAccept=text/plain

2 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0300-2896(03)75361-7

Archivos de Bronconeumologia

2 January 2024

published in

1 reference

3 December 2017

39

1 reference

3 December 2017

5

1 reference

3 December 2017

195-202

1 reference

Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2803%2975361-7

7 January 2021

Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2803%2975361-7

7 January 2021

The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2803%2975361-7

7 January 2021

Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2803%2975361-7

7 January 2021

Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2803%2975361-7

7 January 2021

[Treatment of chronic bronchitis and chronic pulmonary obstructive disease in primary care]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2803%2975361-7

7 January 2021

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2803%2975361-7

7 January 2021

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2803%2975361-7

7 January 2021

[Clinical guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2803%2975361-7

7 January 2021

Pharmacoeconomic evaluation of COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2803%2975361-7

7 January 2021

The reality of drug use in COPD: the European perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2803%2975361-7

7 January 2021

[Guidelines on the diagnosis and treatment of chronic obstructive lung disease. The SEPAR Working Group. The Spanish Society of Pneumology and Thoracic Surgery]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2803%2975361-7

7 January 2021

Managing patients with chronic bronchitis: from primary prevention to advance directives

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2803%2975361-7

7 January 2021

Efficacy of salmeterol xinafoate in the treatment of COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2803%2975361-7

7 January 2021

The efficacy and safety of salmeterol compared to theophylline: meta-analysis of nine controlled studies

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2803%2975361-7

7 January 2021

EUROSCOP, ISOLDE and the Copenhagen city lung study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2803%2975361-7

7 January 2021

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2803%2975361-7

7 January 2021

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2803%2975361-7

7 January 2021

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2803%2975361-7

7 January 2021

Quality of life changes in COPD patients treated with salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2803%2975361-7

7 January 2021

The costs of treating COPD in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2803%2975361-7

7 January 2021

Identifiers

1 reference

3 December 2017

1 reference